By Carolyn Gregoire — 2020
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
Read on neo.life
CLEAR ALL
Panel: Jae Sevelius, PhD, Monnica Williams, PhD, Paula Graciela Kahn, and LisaNa RedBear, moderated by Ismail Ali, JD A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca,...
2
Dr. Monnica T. Williams discusses her work in assessing racial trauma and mental health disparities in African-American communities.
1
Recently, there has been much excitement in the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, posttraumatic stress disorder, addiction, end-of-life anxiety, and others. However, not everyone has been included.
Dr. Monnica Williams is a professor, clinical psychologist, and the Canada Research Chair for Mental Health Disparities at the University of Ottawa.
Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.
A collaboration between MAPS and the Centre for Psychedelic Research at Imperial College London, Antwan Saca, Leor Roseman, Ph.D., and Natalie Ginsberg, M.S.W.
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
TiHKAL: The Continuation is the sequel to PiHKAL: A Chemical Love Story. TiHKAL is written about a family of psychoactive drugs known as tryptamines with TiHKAL being an acronym for "Tryptamines I Have Known and Loved”. Like its predecessor, it is divided into two parts.
An acronym for “Phenethylamines I Have Known and Loved”, the book spans autobiography, organic chemistry, politics, ethnobotany, and psychopharmacology. PiHKAL is divided into two parts, the first of which is a fictionalized autobiographical 'novel', The Love Story.
"A genuine spiritual quest. . . . Extraordinary.